Sector ratings cbdMD, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:00 2026-05-13 pm EDT			5-day change	1st Jan Change
0.7958 ^USD	+1.48%		-12.80%	-41.05%

Apr. 06	Hawkeye Systems, Inc. Announces President and Directorate Appointments	CI
Apr. 01	CbdMD, Inc. Announces Launch of Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility
CBDMD, INC.	8.35M	-	-	-	-	-
ELI LILLY AND COMPANY	906B		A
JOHNSON & JOHNSON	555B		BBB
ABBVIE INC.	368B	-	AA	-	-
ROCHE HOLDING AG	326B		AA
ASTRAZENECA PLC	289B		A
NOVARTIS AG	285B		AAA
MERCK & CO., INC.	280B		A
NOVO NORDISK A/S	208B		A
AMGEN INC.	182B		A
GILEAD SCIENCES, INC.	165B		AA
PFIZER INC.	148B		A
BRISTOL-MYERS SQUIBB COMPANY	115B		A
VERTEX PHARMACEUTICALS INCORPORATED	115B		AA
SANOFI	102B		AA
GSK PLC	102B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	81.37B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	54.61B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	51.96B		AA
BAYER AG	43.68B		AA
Average	218.87B		AA
Weighted average by Cap.			AA